Kakanang Piyarungsri

Dr. Kakanang Piyarungsri

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
KPKakanang Piyarungsri
Kakanang Piyarungsri
STSahatchai Tangtrongsup
Sahatchai Tangtrongsup
NTNiyada Thitaram
Niyada Thitaram
PLPhatthamaporn Lekklar
Phatthamaporn Lekklar
AKAtiratt Kittinuntasilp
Atiratt Kittinuntasilp
Feline lower urinary tract disease (FLUTD) is a common problem in cats. The objectives of the study were to determine the prevalence, clinical signs, and causes of FLUTD and the risk factors for FLUTD. The medical records of 3486 cats visiting Chiang Mai University Small Animal Veterinary Teaching Hospital (VTH) between November 2016 and October 2017 were reviewed. An age-matched case-control study was performed to determine the risk factors for FLUTD by comparing 78 cats with FLUTD and 78 clinically normal age-matched cats. For each animal, potential risk data were obtained from medical records and cat owner interviews; these were analysed for associations with FLUTD. Multivariable logistic regression analysis was performed to estimate the odds ratios and to adjust for expected confounding factors. The prevalence of FLUTD in cats visiting the Chiang Mai University Veterinary Teaching Hospital was 2.2%. The most common clinical signs identified were urethral obstruction (55.1%) and haematuria (23.1%). The most common diagnoses were feline idiopathic cystitis (FIC) (57.7%) and urolithiasis (struvite) (18%). The multivariable logistic regression analysis results indicated that FLUTD was most likely to be diagnosed in castrated male cats. FIC and urolithiasis were the most common diagnoses in cats with FLUTD, and male sex and castration increased the risk of FLUTD.


1 January 2021 in Journal of Veterinary Science
Verified
Journal Article
Open access
PDF file
NSNisakorn Songaksorn
Nisakorn Songaksorn
WPWilaiwan Petsophonsakul
Wilaiwan Petsophonsakul
KPKidsadagon Pringproa
Kidsadagon Pringproa
KNKannika Na-Lampang
Kannika Na-Lampang
Nattawooti SthitmateeNattawooti Sthitmatee
Nattawooti Sthitmatee
KTKriangkrai Thongkorn
Kriangkrai Thongkorn
Songaksorn N, et al. J Vet Sci. 2021 May;22(3):e38. https://doi.org/10.4142/jvs.2021.22.e38

9 January 2023 in Frontiers in Veterinary Science
Verified
Journal Article
Open access
PPPattiya Pila
Pattiya Pila
PCPhongsakorn Chuammitri
Phongsakorn Chuammitri
PPPrapas Patchanee
Prapas Patchanee
KPKidsadagon Pringproa
Kidsadagon Pringproa
KPKakanang Piyarungsri
Kakanang Piyarungsri
Chronic kidney disease (CKD) is a frequent condition in elderly cats. Bcl-2 is linked to kidney disease through the processes of apoptosis and fibrosis. The purpose of this study is to examine Bcl-2 levels in CKD and clinically healthy age-matched cats in order to evaluate the relationship between Bcl-2 levels, signalment, and blood parameters in cats with CKD. The circulating levels of Bcl-2 were determined using an immunoassay in twenty-four CKD cats and eleven clinically healthy age-matched cats by the utilization of the general linear model (GLM), Pearson correlation, principal component analysis (PCA), ROC curves, the Cox hazard model, and Kaplan–Meier survival analysis. These were all conducted in order to explore Bcl-2 levels and their connection with other variables. The Bcl-2 immunohistochemical intensity was graded in each glomerulus and tubulointerstitium. McNemar's test was performed in order to compare the expression of Bcl-2 in the two renal tissue sites. The circulating Bcl-2 of CKD cats was significantly lower than those of clinically healthy age-matched cats (P= 0.034). The presence of circulating Bcl-2 (P< 0.01) and the severity of CKD (P= 0.02) were both linked with the survival time of cats with CKD. The area under the curve (AUC) of Bcl-2 for detection of CKD was 0.723. In cats, decreased circulating Bcl-2 was associated with increased blood BUN, creatinine levels, and CKD severity. Bcl-2 protein expression was reduced in the renal tissues of CKD cats as the disease progressed, resulting in a decrease in their survival time. This study demonstrated that Bcl-2 may be effective in diagnosing feline CKD.

22 December 2023 in Journal of Feline Medicine and Surgery
Verified
Journal Article
Open access
KPKakanang Piyarungsri
Kakanang Piyarungsri
PCPhongsakorn Chuammitri
Phongsakorn Chuammitri
KPKidsadagon Pringproa
Kidsadagon Pringproa
PPPattiya Pila
Pattiya Pila
SSSaralee Srivorakul
Saralee Srivorakul
RPRosama Pusoonthornthum
Rosama Pusoonthornthum
Objectives: The aim of the present study was to compare the circulating transforming growth factor-beta (TGF-β) of clinically normal age-matched and naturally occurring chronic kidney disease (CKD) cats and to determine the correlation between the TGF-β expression and histopathological changes in cats with CKD. Methods: A total of 11 clinically normal age-matched and 27 cats with naturally occurring CKD were included in this study. Circulating TGF-β was quantified by immunoassays. Kaplan–Meier analysis was used to calculate the association between survival time and the concentration of circulating TGF-β. A general linear model was used to compare the circulating TGF-β between groups. Immunohistochemical analyses revealed TGF-β expression in renal tissues from cats with CKD that died during the study (n = 7) and in available archived renal tissue specimens taken at necropsy from cats that had previous CKD with renal lesions (n = 10). Correlations of the TGF-β expression and clinical parameters (n = 7) and histopathological changes (n = 17) were analysed using Spearman’s rank correlation. Results: The median survival time of cats with a lower concentration of circulating TGF-β was shorter than that of cats with a higher concentration. The area under the curve of circulating TGF-β for predicting CKD was 0.781, indicating good differentiation. The study indicated a significant difference in circulating TGF-β concentrations between clinically normal cats and those with CKD and demonstrated that TGF-β expression is correlated with tubular atrophy. Conclusions and relevance: The study findings suggest that decreased serum TGF-β and tubular atrophy with TGF-β immunoreactivity may be significant in cats with CKD.

17 January 2025 in Animals
Verified
Journal Article
Open access
PDF file
CIChanyanuch Intachat
Chanyanuch Intachat
PCPhongsakorn Chuammitri
Phongsakorn Chuammitri
BSBenjaporn Sornpet
Benjaporn Sornpet
PPPrapas Patchanee
Prapas Patchanee
NMNawin Manachai
Nawin Manachai
KPKakanang Piyarungsri
Kakanang Piyarungsri
Chronic kidney disease (CKD) is prevalent among older cats. The transforming growth factor beta 1 (TGF-β1) pathway is associated with renal fibrosis. TGF-β1 signaling through the non-canonical/smad-independent pathway activates mitogen-activated protein kinase (MAPK) signaling, which is linked to fibrosis and apoptosis. The MAPK pathway regulates the Bcl-2 protein family, which is known for its anti-apoptosis properties. This study aimed to quantify the mRNA expression of the TGFβ, MAPK, and Bcl2 genes and the protein expression of TGF-β1 and MAPK in feline kidney cells and tissue. A gene expression analysis was conducted using qPCR to calculate the relative gene expression, while the protein expression was assessed through Western blot analysis. Immunohistochemistry staining of TGF-β1 and MAPK was performed on feline kidney tissue. The results revealed the significant upregulation of TGFβ (p = 0.001) and considerable downregulation of Bcl2 (p = 0.010) in doxorubicin-treated feline kidney cells. The immunostaining levels of TGF-β1 and MAPK were higher in the kidney tissue of cats with CKD than in non-CKD cats. However, there was no difference in TGFβ, MAPK, or Bcl2 gene expression in CKD vs. non-CKD cats. The findings suggest that TGF-β1 and Bcl-2 are associated with renal fibrosis and apoptosis in feline kidney cells. A deeper understanding of the TGF-β1 pathway could enable veterinarians to monitor disease progression and mitigate complications in feline CKD.